Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in OVID — Ovid Therapeutics Inc.

CIK 1446194 BALA CYNWYD, PA
Back to OVID Full portfolio

Position in OVID

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$189,914
-$4,133,744 QoQ
Shares Held
70,600
-96.4% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 130 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OVID Over Time

Shares Held

Position Value (USD)

Derivatives in OVID

reported options exposure · as of Jun 30, 2026
CallValue
$303,701
CallShares
112,900
PutValue
$198,791
PutShares
73,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. OVID ranks #235 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in OVID

Export CSV
42 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $198,791 73,900
2026-06-30 $303,701 112,900
2026-06-30 $189,914 70,600
2026-03-31 $353,646 159,300
2026-03-31 $142,524 64,200
2026-03-31 $4,323,658 1,947,594
2025-12-31 $557,036 341,740
2025-12-31 $23,309 14,300
2025-12-31 $19,560 12,000
2025-09-30 $75,530 58,100
2025-09-30 $765,821 589,094
2025-06-30 $75,980 230,245
2025-03-31 $25,922 83,084
2024-12-31 $42,142 45,120
2023-12-31 $71,548 22,220
2023-06-30 $55,622 16,958
2023-03-31 $422,516 163,766
2022-12-31 $22,411 12,049
2022-06-30 $24,295 11,300
2022-03-31 $966,724 307,874
2022-03-31 $79,442 25,300
2021-12-31 $379,422 118,200
2021-12-31 $919,247 286,370
2021-09-30 $662,810 197,265
2021-09-30 $95,088 28,300
2021-09-30 $665,616 198,100
2021-06-30 $87,584 22,400
2021-06-30 $417,275 106,720
2021-06-30 $801,550 205,000
2021-03-31 $750,144 186,603
2021-03-31 $734,454 182,700
2021-03-31 $573,252 142,600
2020-12-31 $23,100 10,000
2020-12-31 $306,075 132,500
2020-12-31 $376,897 163,159
2020-09-30 $264,614 46,100
2020-09-30 $171,511 29,880
2020-09-30 $184,254 32,100
2020-06-30 $512,215 69,500
2020-06-30 $179,091 24,300
2020-06-30 $517,985 70,283
2020-03-31 $910,991 305,702

Report a Problem

Category
Description
Email (optional, for follow-up)